Lyme Disease Serology
Aid in the diagnosis of Lyme disease in individuals with clinical signs and symptoms consistent with Lyme disease. Lyme disease should be considered based on the presence of typical signs and symptoms of infection in patients with a history of possible exposure to infected ticks. This panel utilizes FDA-cleared assays following the modified two-tiered testing (MTTT) algorithm.
Biomarkers in this category
5 biomarkers · optimal ranges shown
produced once an infection has been going on for a whil
IgM antibodies reflect a relatively recent infection
looks for antibodies in the blood to the bacteria that causes Lyme disease